Prerequisites for a dry powder inhaler for children with cystic fibrosis.

Por Anne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, Bart L Rottier, Anne H de Boer
Publicado em 2017-01-01

Effect of inhaler design variables on paediatric use of dry powder inhalers.

Por Anne J Lexmond, Tonnis J Kruizinga, Paul Hagedoorn, Bart L Rottier, Henderik W Frijlink, Anne H de Boer
Publicado em 2014-01-01

Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma

Por Fajri Gafar, Ilse M. Boudewijn, Claire A. Cox, Judith M. Vonk, Siebrig Schokker, Anne J. Lexmond, Henderik W. Frijlink, Paul Hagedoorn, Dirkje S. Postma, Maarten van den Berge
Publicado em 2018-12-01